Senolytic nanoplatform to target and eliminate skin cancer Zombie cells - Nano4Zombie

Project summary

Need: With increased age, there is an increase in senescent cells(SC) which can contribute to tumorigenesis. Elimination of cancer-associated SC is a new promising approach to prevent or delay cancer recurrence. However, many of the drugs used as senolytics have shown adverse effects at high doses in clinical trials or low activity. Novel strategies to increase selectivity, bioavailability and activity are needed in order to enhance the effectiveness and safety. Aims: i)Develop new quercetin derivatives with improved action towards cancer SC;ii) Develop a nanoplatform to eradicate skin cancer SC by combining magnetic hyperthermia and senolytic drugs. iii) Analyse the functional effects of SC-derived extracellular vesicles released from treated and untreated skin cancer SC on cells constituting the tumour microenvironment. Application: Aside from a novel and promising anticancer strategy, it could be expanded to other areas such as ageing. Impact: New method to eliminate skin cancer SC.

Project Details

Call

Call 2022


Call Topic

New strategies for advanced material-based technologies for health applications


Project start

01.09.2023


Project end

31.08.2026


Total project costs

1.135.474 €


Total project funding

1.086.285 €


TRL

2 - 4


Coordinator

Dr. María Moros

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS, CALLE SERRANO 117, 28006 MADRID, Spain


Partners and Funders Details

Consortium Partner   Country Funder
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
https://www.csic.es/es
Research org. Spain ES-AEI
University of Rzeszów
https://www.ur.edu.pl/
University Poland PL-NCN
University of Warsaw
https://www.uw.edu.pl/
University Poland PL-NCN
Latvian Biomedical Research and Study Centre
https://biomed.lu.lv/home/
Research org. Latvia LV-LZP

Keywords

advanced multifunctional materials, nanoparticles, drug delivery systems, cancer therapy, Magnetic hyperthermia, Senescent cells